Phoenix Biotech Acquisition Corp. (PBAXU) has a market capitalization of $36.54M and trades at $10.37. The 52-week range is 9.82-11.73.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -47.1, Earnings Per Share (EPS) of $-0.22.
The stock has a beta of 0.04, operates in the Financial Services sector.
